menu ☰
menu ˟

Treat-and-extend with ranibizumab comparable to monthly treatment for wet AMD

22 Jul 2018
Peter KertesVANCOUVER, British Columbia — A 24-month treat-and-extend analysis trial with ranibizumab for patients with neovascular age-related macular degeneration showed statistically significant improvements in best corrected visual acuity at 12...

Click here to view the full article which appeared in

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.